Q: Hi 5i,
I would like your assessment of a New Issue/IPO just made available on TD's Direct Investing web-site. It is for approx $250 million of common shares in Aurigen Capital Limited. It seems this company has been in existance since 2007 and offers Life reinsurance to primary insurers. The CEO (Alan Ryder) has
previously led the launch, growth and operation of two other successful reinsurance start-ups and previously (2007) raised
$505 million of equity capital from respected private equity &
industry investors. Is the CEO and other members of the mgmt team known to 5iResearch? Who are their competitors in the CDN market? Do you recommend purchasing this on the IPO, later after it settles, or not at all for sector reasons? (price has yet to be determined...)
Thanks for your great service!
Scot
I would like your assessment of a New Issue/IPO just made available on TD's Direct Investing web-site. It is for approx $250 million of common shares in Aurigen Capital Limited. It seems this company has been in existance since 2007 and offers Life reinsurance to primary insurers. The CEO (Alan Ryder) has
previously led the launch, growth and operation of two other successful reinsurance start-ups and previously (2007) raised
$505 million of equity capital from respected private equity &
industry investors. Is the CEO and other members of the mgmt team known to 5iResearch? Who are their competitors in the CDN market? Do you recommend purchasing this on the IPO, later after it settles, or not at all for sector reasons? (price has yet to be determined...)
Thanks for your great service!
Scot